SynthesisFrontiers in immunology2022

Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.

Peng Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.